Physician profile
Larry Johnson
NPI 1841292000
$1,413.32
in general payments reported to CMS, 2019-2025
11 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $21.51 · 2021: $35.45 · 2022: $1,000 · 2023: $84.56 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $187.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $990.39 | 2022-2025 | Spinejack, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $99.14 | 2022-2023 | |
| Medtronic, INC. | $80.58 | 2025 | Kyphon Express II Kyphopak Tray |
| Bard Peripheral Vascular, INC. | $77.70 | 2019 | |
| Inari Medical, INC. | $35.45 | 2021 | |
| Angiodynamics, INC. | $31.24 | 2019 | |
| Terumo Medical Corporation | $26.25 | 2019 | |
| Ge Healthcare | $21.51 | 2020 | |
| Cook Medical LLC | $18.11 | 2019 | |
| Siemens Medical Solutions USA, INC. | $17.57 | 2023 | Magnetom Free.Max |
| Ekos Corporation | $15.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.